$2.23 Billion is the total value of Casdin Capital, LLC's 45 reported holdings in Q3 2020. The portfolio turnover from Q2 2020 to Q3 2020 was 21.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| NVTA | INVITAE CORP | $391,621,000 | +43.1% | 9,033,943 | 0.0% | 17.54% | +8.3% | |
| BLFS | Buy | BIOLIFE SOLUTIONS INC | $169,013,000 | +113.2% | 5,840,107 | +20.4% | 7.57% | +61.3% |
| RLAY | New | RELAY THERAPEUTICS INC | $162,221,000 | – | 3,808,894 | +100.0% | 7.26% | – |
| BPMC | BLUEPRINT MEDICINES CORP | $143,685,000 | +18.8% | 1,550,000 | 0.0% | 6.43% | -10.1% | |
| FATE | FATE THERAPEUTICS INC | $121,909,000 | +16.5% | 3,050,000 | 0.0% | 5.46% | -11.9% | |
| MYOK | MYOKARDIA INC | $118,607,000 | +41.1% | 870,000 | 0.0% | 5.31% | +6.8% | |
| ALNY | Buy | ALNYLAM PHARMACEUTICALS INC | $90,272,000 | +10.8% | 620,000 | +12.7% | 4.04% | -16.2% |
| TWST | TWIST BIOSCIENCE CORP | $75,970,000 | +67.7% | 1,000,000 | 0.0% | 3.40% | +26.9% | |
| SRPT | SAREPTA THERAPEUTICS INC | $74,428,000 | -12.4% | 530,000 | 0.0% | 3.33% | -33.7% | |
| AGIO | Buy | AGIOS PHARMACEUTICALS INC | $61,250,000 | +7.0% | 1,750,000 | +63.6% | 2.74% | -19.0% |
| RVMD | Buy | REVOLUTION MEDICINES INC | $56,882,000 | +35.0% | 1,634,535 | +22.5% | 2.55% | +2.2% |
| GBIO | GENERATION BIO CO | $49,803,000 | +47.2% | 1,611,214 | 0.0% | 2.23% | +11.4% | |
| BLUE | Sell | BLUEBIRD BIO INC | $49,364,000 | -26.8% | 915,000 | -17.2% | 2.21% | -44.6% |
| BNR | Buy | BURNING ROCK BIOTECH LTDsponsored ads | $48,208,000 | +3.1% | 1,922,150 | +11.1% | 2.16% | -22.0% |
| DNLI | DENALI THERAPEUTICS INC | $46,937,000 | +48.2% | 1,310,000 | 0.0% | 2.10% | +12.1% | |
| CDXS | Sell | CODEXIS INC | $46,784,000 | -12.5% | 3,985,000 | -15.1% | 2.10% | -33.8% |
| CDNA | CAREDX INC | $45,275,000 | +7.1% | 1,193,335 | 0.0% | 2.03% | -19.0% | |
| PACB | New | PACIFIC BIOSCIENCES CALIF IN | $44,415,000 | – | 4,500,000 | +100.0% | 1.99% | – |
| BGNE | BEIGENE LTDsponsored adr | $42,966,000 | +52.0% | 150,000 | 0.0% | 1.92% | +15.1% | |
| ALLO | Buy | ALLOGENE THERAPEUTICS INC | $35,636,000 | +33.2% | 945,000 | +51.2% | 1.60% | +0.8% |
| ADPT | ADAPTIVE BIOTECHNOLOGIES COR | $34,679,000 | +0.5% | 713,125 | 0.0% | 1.55% | -23.9% | |
| ADVM | Buy | ADVERUM BIOTECHNOLOGIES INC | $28,325,000 | -27.3% | 2,750,000 | +47.5% | 1.27% | -45.0% |
| MGTA | MAGENTA THERAPEUTICS INC | $22,753,000 | -9.5% | 3,346,034 | 0.0% | 1.02% | -31.5% | |
| CRSP | CRISPR THERAPEUTICS AGnamen akt | $22,284,000 | +13.8% | 266,430 | 0.0% | 1.00% | -13.9% | |
| GBT | Buy | GLOBAL BLOOD THERAPEUTICS IN | $21,780,000 | +15.0% | 395,000 | +31.7% | 0.98% | -13.0% |
| AMRS | Buy | AMYRIS INC | $21,579,000 | -5.5% | 7,390,000 | +38.1% | 0.97% | -28.6% |
| CNST | CONSTELLATION PHARMCETICLS I | $19,855,000 | -32.6% | 980,000 | 0.0% | 0.89% | -49.0% | |
| TSHA | New | TAYSHA GENE THERAPIES INC | $18,378,000 | – | 820,440 | +100.0% | 0.82% | – |
| ALEC | Buy | ALECTOR INC | $17,383,000 | -33.9% | 1,650,000 | +53.3% | 0.78% | -50.0% |
| DERMTECH INC | $17,071,000 | -9.7% | 1,428,572 | 0.0% | 0.76% | -31.7% | ||
| ZLAB | ZAI LAB LTDadr | $15,802,000 | +1.3% | 190,000 | 0.0% | 0.71% | -23.4% | |
| BLI | New | BERKELEY LTS INC | $15,272,000 | – | 200,000 | +100.0% | 0.68% | – |
| BMYRT | Buy | BRISTOL-MYERS SQUIBB COright 99/99/9999 | $14,063,000 | +33.2% | 6,250,000 | +111.9% | 0.63% | +0.8% |
| FULC | FULCRUM THERAPEUTICS INC | $11,429,000 | -56.6% | 1,441,176 | 0.0% | 0.51% | -67.2% | |
| SGMO | Sell | SANGAMO THERAPEUTICS INC | $10,206,000 | -21.7% | 1,080,000 | -25.8% | 0.46% | -40.8% |
| IOVA | New | IOVANCE BIOTHERAPEUTICS INC | $9,547,000 | – | 290,000 | +100.0% | 0.43% | – |
| ILMN | ILLUMINA INC | $9,272,000 | -16.6% | 30,000 | 0.0% | 0.42% | -36.9% | |
| BDTX | BLACK DIAMOND THERAPEUTICS I | $8,748,000 | -28.3% | 289,395 | 0.0% | 0.39% | -45.7% | |
| ORTX | Buy | ORCHARD THERAPEUTICS PLCads | $7,686,000 | -22.4% | 1,870,000 | +13.3% | 0.34% | -41.3% |
| DYN | New | DYNE THERAPEUTICS INC | $7,470,000 | – | 370,000 | +100.0% | 0.33% | – |
| TPTX | TURNING POINT THERAPEUTICS I | $6,552,000 | +35.3% | 75,000 | 0.0% | 0.29% | +2.1% | |
| ORIC | ORIC PHARMACEUTICALS INC | $6,290,000 | -25.9% | 251,515 | 0.0% | 0.28% | -43.8% | |
| LEGN | Buy | LEGEND BIOTECH CORPsponsored ads | $4,311,000 | -25.0% | 139,661 | +3.5% | 0.19% | -43.2% |
| STOK | STOKE THERAPEUTICS INC | $4,019,000 | +40.5% | 120,000 | 0.0% | 0.18% | +6.5% | |
| DCPH | DECIPHERA PHARMACEUTICALS IN | $3,335,000 | -14.1% | 65,000 | 0.0% | 0.15% | -35.2% | |
| ZYME | Exit | ZYMEWORKS INC | $0 | – | -130,000 | -100.0% | -0.28% | – |
| VYGR | Exit | VOYAGER THERAPEUTICS INC | $0 | – | -750,000 | -100.0% | -0.56% | – |
| GRTS | Exit | GRITSTONE ONCOLOGY INC | $0 | – | -1,850,373 | -100.0% | -0.73% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-11-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BLUEPRINT MEDICINES CORP | 32 | Q3 2023 | 9.6% |
| ALNYLAM PHARMACEUTICALS INC | 32 | Q3 2023 | 9.9% |
| AGIOS PHARMACEUTICALS INC | 27 | Q2 2022 | 12.1% |
| GLOBAL BLOOD THERAPEUTICS IN | 27 | Q2 2022 | 7.1% |
| FATE THERAPEUTICS INC | 26 | Q3 2023 | 8.3% |
| BIOLIFE SOLUTIONS INC | 22 | Q3 2023 | 14.9% |
| CODEXIS INC | 22 | Q3 2023 | 8.1% |
| SAREPTA THERAPEUTICS INC | 21 | Q3 2023 | 13.6% |
| BLUEBIRD BIO INC | 21 | Q4 2020 | 7.8% |
| ILLUMINA INC | 21 | Q3 2023 | 6.0% |
View Casdin Capital, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Absci Corp | May 08, 2023 | 4,448,260 | 4.8% |
| CODEXIS, INC.Sold out | February 14, 2023 | 0 | 0.0% |
| DermTech, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Invitae Corp | February 14, 2023 | 9,038,388 | 3.7% |
| Magenta Therapeutics, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Tango Therapeutics, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Verve Therapeutics, Inc. | February 14, 2023 | 2,290,571 | 3.7% |
| Tenaya Therapeutics, Inc. | December 07, 2022 | 6,427,200 | 9.9% |
| Fulcrum Therapeutics, Inc. | February 11, 2021 | 1,241,176 | 4.5% |
| Gritstone Oncology, Inc.Sold out | February 11, 2021 | 0 | 0.0% |
View Casdin Capital, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G | 2024-04-18 |
| SC 13D/A | 2024-04-08 |
| 4 | 2024-03-28 |
| 3 | 2024-03-25 |
| 4 | 2024-03-25 |
| 4 | 2024-03-20 |
| SC 13D/A | 2024-03-20 |
| 4 | 2024-03-06 |
| 4 | 2024-03-06 |
| 13F-HR | 2024-02-14 |
View Casdin Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.